Cargando…
IMMU-13. DUAL IGF1R/IR INHIBITOR IN COMBINATION WITH GD2-CAR T-CELLS AS A POTENT THERAPEUTIC STRATEGY FOR H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS
Diffuse midline gliomas (DMG) are aggressive paediatric brain tumors for which there is no effective treatment. Recent pre-clinical studies suggest that adoptive transfer of chimeric antigen receptor (CAR) T-cells targeting the disialoganglioside antigen GD2 (GD2-CAR) has a significant therapeutic p...
Autores principales: | de Billy, Emmanuel, pellegrino, Marsha, De Angelis, Biagio, Businaro, Pietro, Orlando, Domenico, Pericoli, Giulia, Petrilli, Lucia Lisa, Rossi, Sabrina, Ferretti, Roberta, Maestro, Nicola, Massimi, Luca, Pezzullo, Marco, De Stefanis, Cristiano, Rota, Rossella, Ferrari, Francesco, Salviato, Elisa, Carai, Andrea, Caruana, Ignazio, Locatelli, Franco, Mastronuzzi, Angela, Quintarelli, Concetta, Vinci, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715675/ http://dx.doi.org/10.1093/neuonc/noaa222.369 |
Ejemplares similares
-
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent
anti-tumor activity in diffuse midline glioma H3K27M-mutant
por: de Billy, Emmanuel, et al.
Publicado: (2021) -
IMMU-22. Safely targeting GD2 in thalamic diffuse midline glioma with mRNA CAR T cells
por: Foster, Jessica, et al.
Publicado: (2022) -
IMMU-17. USE OF MRNA FOR SAFE AND EFFECTIVE GD2-DIRECTED CAR T CELLS TO TREAT DIFFUSE MIDLINE GLIOMAS
por: Foster, Jessica, et al.
Publicado: (2021) -
IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas
por: Labiano, Sara, et al.
Publicado: (2022) -
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas
por: Arnone, Claudia Manuela, et al.
Publicado: (2021)